ANDA 77345, held by Heritage Pharma Avet. Sertraline Hydrochloride.
As of Nov 16, 2026, ANDA 77345 (Sertraline Hydrochloride), held by Heritage Pharma Avet, was first approved by FDA on Feb 6, 2007, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 6, 2007 | Original application | Approved | None posted |
| Sertraline HydrochlorideEQ 25MG BASE · tablet;oral | Sertraline Hydrochloride | Discontinued |
| Sertraline HydrochlorideEQ 50MG BASE · tablet;oral | Sertraline Hydrochloride | Discontinued |
| Sertraline HydrochlorideEQ 100MG BASE · tablet;oral | Sertraline Hydrochloride | Discontinued |
| Jun 3, 2026 | Supplement 14Labeling · Standard review | Approved | None posted |
| Aug 30, 2022 | Supplement 13Labeling · Standard review | Approved | None posted |
| Nov 17, 2008 | Supplement 11Labeling | Approved | None posted |
| Apr 17, 2008 | Supplement 6Labeling | Approved | None posted |
| Sep 12, 2007 | Supplement 3Labeling | Approved | None posted |
| Jun 19, 2007 | Supplement 2Labeling | Approved | None posted |
| Feb 6, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters